Stories – Innovation

Dr. Elisa Kieback and Dr. Elisabeth von Weizsäcker drive "T-knife" forward

Dr. Elisa Kieback and Dr. Elisabeth von Weizsäcker drive "T-knife" forward T-knife Therapeutics is one of the most successful start-ups in the biotech scene. Founded in 2018 as a spin-off of the Max Delbrück Center for Molecular Medicine (MDC) with the support of Charité – Universitätsmedizin Berlin, its mission is to develop therapies that can combat cancer with the help of patients’ immune systems. Over the course of many years, the research team led by Professor Thomas Blankenstein has worked towards genetically modifying human T cells in such a way that their receptors can target and destroy specific tumor cells. Using this unique technology, the first T-cell receptor gene therapy in Germany is now being tested in a clinical trial.

Eileen Bauer and Thomas Krakowiak promote occupational health

Eileen Bauer and Thomas Krakowiak promote occupational health An own prevention and fitness center for the Campus? Regular sports courses and health days on topics such as stress reduction or nutrition? And all of this is supported jointly by the institutions and companies on campus? Since 2016, there has been

DR. LEIF SCHRÖDER AND DR. STEPHAN PRITZ DEVELOP NEW MRI CONTRAST AGENT

DR. LEIF SCHRÖDER AND DR. STEPHAN PRITZ DEVELOP NEW MRI CONTRAST AGENT Magnetic resonance imaging (MRI) is a method for diagnosing diseases and monitoring the course of therapy. It produces sectional images of the human body without using harmful radiation. Typically, the water molecules

Dr. Andreas Eckert founds and finances biotechnology and medical technology companies

Dr. Andreas Eckert founds and finances biotechnology and medical technology companies Dr. Andreas Eckert is not directly involved in research to find cures for diseases, but he has dedicated his career to the life sciences. His objective is to invest in promising companies in the early phase of their development, which he does with

Dr. Ralf Krähmer provides drugs with a protective shield for their journey through the body

Dr. Ralf Krähmer provides drugs with a protective shield for their journey through the body Dr. Ralf Krähmer never thought he would one day found a company in Berlin-Buch. Following his chemistry studies in Leipzig, Dr. Krähmer went to the U.S. for a research stay. From there he went to Switzerland and then on to Berlin, where he for the

Robert Fischer, MD and Dr. Karen Uhlmann are developing a new treatment for atrial fibrillation

Robert Fischer, MD and Dr. Karen Uhlmann are developing a new treatment for atrial fibrillation The prospect that the first clinical trials will lead to the successful treatment of patients inspires and motivates the team of OMEICOS Therapeutics GmbH. All previous data suggest that the scientists and founders have for the first time found a

News Leben

Freiluftkino Buch startet am 6. Mai

Das Freiluftkino Buch widmet sich in diesem Jahr unter dem Titel "Grenzenlos" den Themen Migration, Flucht, Mobilität und Integration und zeigt möglichst mehrsprachige Filme.

more ...

Fördermittel zur Unterstützung geflüchteter Menschen aus der Ukraine in Pankow

Beantragung beim Integrationsbüro

more ...

Pankower Wochen gegen Rassismus bieten vom 14. bis 27. März vielfältiges Programm

Durch Buch und Karow gibt es am 12. März eine Fahrraddemo "Auf/ Rollen gegen Rassismus"

more ...

Events Buch Berlin

26.05.2022, 15:00
"Wildnis am Stadtrand - ehemalige Rieselfelder

mit Antonia Gerke und Gastexperten

more ...

28.05.2022, 16:00
Sonderkonzert: „Klassik im Quartier“ mit dem Logos Quartett

Das Logos Quartett wurde von Mitgliedern der Bürgersinfonie gegründet und stellt sich erstmals vor

more ...

02.06.2022, 09:00
ZUKUNFTSWERKSTATT zur Bewegungsförderung Älterer im Bezirk Pankow – Buch, Karow

Alle Interessierten sind herzlich eingeladen

more ...

This website is supported by: